腎がん--小分子物質との比較,単剤投与の意義 (特集血管新生阻害剤の効果と功罪 ; Bevacizumab)

腎がん--小分子物質との比較,単剤投与の意義

(特集血管新生阻害剤の効果と功罪 ; Bevacizumab)

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

CiNii Research
Search Service
You can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Check the holdings of this book

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Material Type: 記事
Title: 腎がん--小分子物質との比較,単剤投与の意義
Author/Editor: 三木恒治
本郷文弥
Series Title: 特集血管新生阻害剤の効果と功罪 ; Bevacizumab
Author Heading: 三木恒治
本郷文弥
Alternative Title: Bevacizumab for metastatic renal cell cancer
Periodical title: 腫瘍内科 = Clinical oncology / 腫瘍内科編集委員会編
No. or year of volume/issue: 5(6) (通号 30) 2010.6
Volume: 5
Issue: 6
Sequential issue number: 30
Pages: 580～583
Publication date of volume/issue (W3CDTF): 2010-06
ISSN (Periodical Title): 1881-6568
ISSN-L (Periodical Title): 1881-6568
Publication (Periodical Title): 東京 : 科学評論社
Place of Publication (Country Code): JP
Text Language Code: jpn
Subject Heading: renal cell cancer
bevacizumab
interferon alfa
NDLC: ZS34
Target Audience: 一般
Holding library: 国立国会図書館
Call No.: Z74-F287
Data Provider (Database): 国立国会図書館 : 国立国会図書館雑誌記事索引
https://ndlsearch.ndl.go.jp
Bibliographic ID (NDL): 10774110
http://id.ndl.go.jp/bib/10774110
Bibliographic Record Category (NDL): 632